124 related articles for article (PubMed ID: 26004343)
1. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.
Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL
Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C
Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system.
Miller CP; Fung M; Jaeger-Ruckstuhl CA; Xu Y; Warren EH; Akilesh S; Tykodi SS
Neoplasia; 2023 Dec; 46():100948. PubMed ID: 37944353
[TBL] [Abstract][Full Text] [Related]
4. BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression.
Pan T; Liu F; Hao X; Wang S; Wasi M; Song JH; Lewis VO; Lin PP; Moon B; Bird JE; Panaretakis T; Lin SH; Wu D; Farach-Carson MC; Wang L; Zhang N; An Z; Zhang XH; Satcher RL
Cancer Lett; 2024 Aug; 596():217009. PubMed ID: 38849015
[TBL] [Abstract][Full Text] [Related]
5. Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology.
Somova M; Simm S; Padmyastuti A; Ehrhardt J; Schoon J; Wolff I; Burchardt M; Roennau C; Pinto PC
Sci Rep; 2024 Apr; 14(1):9357. PubMed ID: 38653823
[TBL] [Abstract][Full Text] [Related]
6. HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Stickel JS; Weinzierl AO; Hillen N; Drews O; Schuler MM; Hennenlotter J; Wernet D; Müller CA; Stenzl A; Rammensee HG; Stevanović S
Cancer Immunol Immunother; 2009 Sep; 58(9):1407-17. PubMed ID: 19184600
[TBL] [Abstract][Full Text] [Related]
7. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids.
Xu X; Gurski LA; Zhang C; Harrington DA; Farach-Carson MC; Jia X
Biomaterials; 2012 Dec; 33(35):9049-60. PubMed ID: 22999468
[TBL] [Abstract][Full Text] [Related]
8. 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages.
Habanjar O; Diab-Assaf M; Caldefie-Chezet F; Delort L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830082
[TBL] [Abstract][Full Text] [Related]
9. Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma.
Ortiz Jordan LM; Vega VF; Shumate J; Peles A; Zeiger J; Scampavia L; Spicer TP
SLAS Discov; 2024 Apr; 29(3):100141. PubMed ID: 38218316
[TBL] [Abstract][Full Text] [Related]
10. Development of a New Focal Mouse Model of Bone Metastasis in Renal Cell Carcinoma.
Oya K; Tsuchie H; Nagasawa H; Hongo M; Kasukawa Y; Kudo D; Shoji R; Kasama F; Kawaragi T; Watanabe M; Tominaga K; Miyakoshi N
In Vivo; 2024; 38(3):1074-1078. PubMed ID: 38688604
[TBL] [Abstract][Full Text] [Related]
11. Construction of higher-order cellular microstructures by a self-wrapping co-culture strategy using a redox-responsive hydrogel.
Ramadhan W; Kagawa G; Moriyama K; Wakabayashi R; Minamihata K; Goto M; Kamiya N
Sci Rep; 2020 Apr; 10(1):6710. PubMed ID: 32317652
[TBL] [Abstract][Full Text] [Related]
12. Modelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy.
Suurmond CE; Leeuwenburgh SCG; van den Beucken JJJP
Cell Prolif; 2024 Jun; ():e13693. PubMed ID: 38899562
[TBL] [Abstract][Full Text] [Related]
13. A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of β cells.
Yang K; Lee M; Jones PA; Liu SS; Zhou A; Xu J; Sreekanth V; Wu JLY; Vo L; Lee EA; Pop R; Lee Y; Wagner BK; Melton DA; Choudhary A; Karp JM
Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33208361
[TBL] [Abstract][Full Text] [Related]
14. Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.
Liu XD; Hoang A; Zhou L; Kalra S; Yetil A; Sun M; Ding Z; Zhang X; Bai S; German P; Tamboli P; Rao P; Karam JA; Wood C; Matin S; Zurita A; Bex A; Griffioen AW; Gao J; Sharma P; Tannir N; Sircar K; Jonasch E
Cancer Immunol Res; 2015 Sep; 3(9):1017-29. PubMed ID: 26014097
[TBL] [Abstract][Full Text] [Related]
15. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
16. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
Marlow R; Dontu G
Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
[TBL] [Abstract][Full Text] [Related]
17. Hydrogel-based colorectal cancer organoid co-culture models.
Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
[TBL] [Abstract][Full Text] [Related]
18. Hydrogels to engineer tumor microenvironments in vitro.
Fernando K; Kwang LG; Lim JTC; Fong ELS
Biomater Sci; 2021 Apr; 9(7):2362-2383. PubMed ID: 33438702
[TBL] [Abstract][Full Text] [Related]
19. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
[TBL] [Abstract][Full Text] [Related]
20. Heralding a new paradigm in 3D tumor modeling.
Fong EL; Harrington DA; Farach-Carson MC; Yu H
Biomaterials; 2016 Nov; 108():197-213. PubMed ID: 27639438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
